Extramedullary Manifestation in Multiple Myeloma Bears High Incidence of Poor Cytogenetic Aberration and Novel Agents Resistance

Figure 4

The overall survival (OS) of patients after extramedullary relapse. Median OS of patients in EMD-2 from extramedullary relapse was only 5 months.